GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » Net Margin %

Covalon Technologies (Covalon Technologies) Net Margin % : -18.27% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Covalon Technologies Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Covalon Technologies's Net Income for the three months ended in Dec. 2023 was $-0.64 Mil. Covalon Technologies's Revenue for the three months ended in Dec. 2023 was $3.48 Mil. Therefore, Covalon Technologies's net margin for the quarter that ended in Dec. 2023 was -18.27%.

The historical rank and industry rank for Covalon Technologies's Net Margin % or its related term are showing as below:

CVALF' s Net Margin % Range Over the Past 10 Years
Min: -53.25   Med: -14.59   Max: 120.02
Current: -19.67


CVALF's Net Margin % is ranked better than
68% of 1028 companies
in the Biotechnology industry
Industry Median: -154.37 vs CVALF: -19.67

Covalon Technologies Net Margin % Historical Data

The historical data trend for Covalon Technologies's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Net Margin % Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.87 -51.47 120.02 -53.25 -16.77

Covalon Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.15 -9.63 -8.01 -41.76 -18.27

Competitive Comparison of Covalon Technologies's Net Margin %

For the Biotechnology subindustry, Covalon Technologies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's Net Margin % distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Net Margin % falls into.



Covalon Technologies Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Covalon Technologies's Net Margin for the fiscal year that ended in Sep. 2023 is calculated as

Net Margin=Net Income (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-3.297/19.655
=-16.77 %

Covalon Technologies's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.635/3.476
=-18.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Covalon Technologies  (OTCPK:CVALF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Covalon Technologies Net Margin % Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (Covalon Technologies) Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.